ATRS NASDAQ
Antares Pharma, Inc.
1W: +0.4%
1M: +0.4%
3M: +62.0%
1Y: +37.0%
3Y: +96.8%
5Y: +128.2%
$5.59
Last traded 2022-05-23 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$183M
Revenue
+15.7% YoY
$42M
Net Income
-31.9% YoY
$24M
Free Cash Flow
+847.1% YoY
54.8%
Gross Margin
-7.1%
Op. Margin
-5.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE28.1%
ROA17.9%
ROIC31.7%
Valuation
P/E20.7
P/B5.4
EV/EBITDA10.9
Leverage
Debt/Equity0.15
Current Ratio3.08
Interest Cov.27.6x
Quality Scores
Piotroski F6/9
Altman Z6.25
Beneish M-1.57